Press Room

Article / Feb 25, 2008

Drug safety

Chemistry & Industry, 25 February 2008

Roughly 80% of the key active pharmaceutical ingredients (APIs) in drugs sold in the European Union are imported. The vast majority are made in factories in India and China, which are not inspected by EU inspectors. Unlike the US Food and Drug Administration (FDA), European health authorities do not have a foreign inspection service.

The situation is not helped by the fact that the API supply chain involves...

Also in the Press Room